PRTA Q1 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50,000-97.7% YoY

Gross Profit

$50,000100.0% margin

Operating Income

-$82M-163056.0% margin

Net Income

-$72M-144478.0% margin

EPS (Diluted)

$-1.34

QoQ Revenue Growth

-84.2%

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$73M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$623M

Total Liabilities

$121M

Stockholders' Equity

$502M

Cash & Equivalents

$547M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50,000	$2M	-97.7%
Gross Profit	$50,000	-$43M	+100.1%
Operating Income	-$82M	-$56M	-44.7%
Net Income	-$72M	-$47M	-54.1%

Revenue Segments

License

$50,000100%